In a 2-year CV outcomes trial with semaglutide injection involving patients with type 2 diabetes mellitus and high CV risk, diabetic retinopathy complications (which was a 4-component adjudicated endpoint) occurred in patients treated with semaglutide injection (3%) compared to placebo (1.8%)
Semaglutide injections come in solution form and theres a greater risk of contamination, bacterial, or fungal growth in the solution when using the medication beyond its shelf life
If you have concerns, discuss with your provider
Other changes you might notice include heightened sensitivity to smells, new food aversions or cravings, and mood swings due to fluctuating hormones
Step 5: verify Before removing the needle from the vial, check the syringe one more time
Optimizing outcomes from GLP-1 therapy requires alignment between medication effects, dosing strategy, and clinical oversight